Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study - 21/08/11
, Brian K. Courtney, MD, PhD c, Takashi Nakayama, MD a, Susumu Namikawa, MD, PhD a, Nehiro Kuriyama, MD, PhD a, Tomomi Koizumi, MD, PhD a, Mizuo Nameki, MD, PhD d, Peter J. Fitzgerald, MD, PhD c, Issei Komuro, MD, PhD aRiassunto |
Background |
Plaque stabilization by statins is important for reduction of cardiovascular events but has not been demonstrated enough in vivo. We examined whether statins clinically alter the structure of coronary atherosclerotic plaques using intravascular ultrasound (IVUS) radio-frequency (RF) signal analysis.
Methods |
Fifty consecutive patients undergoing percutaneous coronary intervention were enrolled. Intravascular ultrasound radio-frequency signals were acquired from non–percutaneous coronary intervention-targeted echolucent plaques. The patients were randomly assigned into 2 groups: group S (n = 25) taking atorvastatin 10 mg/d and group C (n = 25) as control. After 6-month follow-up, IVUS-RF signals were sampled at the same plaque sites. Several regions of interest were placed on each plaque. Intravascular ultrasound radio-frequency parameters were blindly calculated in all regions of interests (group S, n = 148; group C, n = 191). Targeted plaque volumes were also measured. Those data were compared between baseline and follow-up.
Results |
In group S after 6 months, plasma low-density lipoprotein level was significantly decreased (133 ± 13 to 87 ± 29 mg/dL, P < .0001), integrated backscatter of IVUS-RF signals was substantially increased (−53.8 ± 4.5 to −51.2 ± 4.9 dB, P < .0001), and plaque volume was significantly reduced, whereas no change was demonstrated in group C.
Conclusions |
These results suggest that statins alter properties as well as volumes of coronary plaques within 6 months, which may be related to plasma low-density lipoprotein reduction. Intravascular ultrasound radio-frequency signal analysis may be useful to evaluate the effects of drugs on stabilization of coronary atherosclerotic plaques.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| This study was supported in part by a Grant-in-Aid for Scientific Research (No. 14570639) from the Japan Society for the Promotion of Science. |
Vol 150 - N° 2
P. 287.e1-287.e7 - agosto 2005 Ritorno al numero
Articolo precedente
- The benefit of cholesterol-lowering medications after coronary revascularization: A population study
- James M. Brophy, Paul Brassard, Chantal Bourgault
- Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke
- Jeff S. Healey, Eugene Crystal, Andre Lamy, Kevin Teoh, Lloyd Semelhago, Stefan H. Hohnloser, Irene Cybulsky, Labib Abouzahr, Corey Sawchuck, Sandra Carroll, Carlos Morillo, Peter Kleine, Victor Chu, Eva Lonn, Stuart J. Connolly
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?